BBH

VanEck Biotech ETF

$188.02

+0.00%

Market closed. Last update: 10:51 PM ET

📎 Investment Objective

The VanEck Biotech ETF (BBH) seeks to track the performance of the MVIS US Listed Biotech 25 Index, which is intended to give investors exposure to the overall performance of companies involved in the biotechnology sector.

Overview

ETF tracking VanEck Biotech ETF

Category Technology

Issuer VanEck

Inception Date 2016-02-01

Market Cap $411.1M

Average Volume N/A

Dividend Yield 0.67%

52-Week Range $140.05 - $189.00

VWAP $188.06

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

🎯 Investment Strategy

The ETF invests in a portfolio of publicly traded companies in the biotechnology industry. The fund's holdings are selected based on their involvement in the development, production, and marketing of biotechnology products and services.

✨ Key Features

Provides exposure to the U.S. biotechnology sector
Diversified portfolio of leading biotech companies
Low expense ratio of 0.00%
Tracks the MVIS US Listed Biotech 25 Index

⚠️ Primary Risks

Sector-specific risk: The fund's performance is closely tied to the biotechnology industry, which can be volatile and subject to rapid changes
Concentration risk: The fund's top holdings can make up a significant portion of the portfolio, increasing exposure to individual company performance
Regulatory risk: Changes in government regulations can significantly impact the biotechnology industry
Market risk: The fund's value can fluctuate with overall market conditions

👤 Best For

The VanEck Biotech ETF may be suitable for investors seeking exposure to the U.S. biotechnology sector as part of a diversified portfolio. Investors should have a higher risk tolerance and a long-term investment horizon to weather the potential volatility of the biotechnology industry.